In addition, we have chosen to apply HORMAD1 overexpression model instead of genetic inhibition, as the acute loss of HR repair genes such as BRCA1 have been shown to be toxic to cancer cells [24, 25]. The gene discussed is HORMAD1; the disease is cancer.